In vivo treatment of human acute promyelocytic leukemia with a histone deacetylase inhibitor, FR901228.

被引：0
|
作者：
Kosugi, H
Towatari, M
Ito, M
Ito, M
Saito, H
Naoe, T
机构：
[1] Nagoya Univ, Sch Med, Dept Internal Med 1, Nagoya, Aichi 466, Japan
[2] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan
[3] Nagoya Univ, Sch Med, Dept Infect Dis, Nagoya, Aichi 466, Japan
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2261
引用
收藏
页码：505A / 505A
页数：1
相关论文
共 50 条
  • [31] Role of the histone deacetylase complex in acute promyelocytic leukaemia
    Lin, RJ
    Nagy, L
    Inoue, S
    Shao, WL
    Miller, WH
    Evans, RM
    NATURE, 1998, 391 (6669) : 811 - 814
  • [32] Role of the histone deacetylase complex in acute promyelocytic leukaemia
    Richard J. Lin
    Laszlo Nagy
    Satoshi Inoue
    Wenlin Shao
    Wilson H. Miller
    Ronald M. Evans
    Nature, 1998, 391 : 811 - 814
  • [33] Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines
    Tsurutani, J
    Soda, H
    Oka, M
    Suenaga, M
    Doi, S
    Nakamura, Y
    Nakatomi, K
    Shiozawa, K
    Yamada, Y
    Kamihira, S
    Kohno, S
    INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (02) : 238 - 242
  • [34] The histone deacetylase inhibitor depsipeptide (FR901228) induces apoptosis via activation of the caspase 8 pathway concurrent with lysine specific acetylation in chronic lymphocytic leukemia cells.
    Aron, JL
    Murphy, T
    Parthun, MR
    Bannerji, R
    Kanakry, C
    Lucas, D
    Flinn, IW
    Marcucci, G
    Grever, MR
    Byrd, JC
    BLOOD, 2001, 98 (11) : 807A - 808A
  • [35] The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells
    Doi, S
    Soda, H
    Oka, M
    Tsurutani, J
    Kitazaki, T
    Nakamura, Y
    Fukuda, M
    Yamada, Y
    Kamihira, S
    Kohno, S
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (11) : 1397 - 1402
  • [36] Preclinical development of histone deacetylase inhibitors for the treatment of pediatric acute leukemia
    DeRyckere, Deborah
    Gore, Lia
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3379S - 3379S
  • [37] Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia
    Xiao, Tong
    Chen, Zhigang
    Xie, Yutong
    Yang, Chao
    Wu, Junhong
    Gao, Lei
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [38] Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
    Quintas-Cardama, A.
    Santos, F. P. S.
    Garcia-Manero, G.
    LEUKEMIA, 2011, 25 (02) : 226 - 235
  • [39] Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
    A Quintás-Cardama
    F P S Santos
    G Garcia-Manero
    Leukemia, 2011, 25 : 226 - 235
  • [40] The histone deacetylase inhibitor depsipeptide (FR901228) enhances the cytotoxic activity of Ad5-TRAIL against prostate and renal tumor cells
    VanOosten, RL
    Moore, JM
    Griffith, TS
    FASEB JOURNAL, 2004, 18 (04): : A62 - A62
12345